| This article has been cited by |
| 1 | Availability, Prices and Affordability of Antibiotics Stocked by Informal Providers in Rural India: A Cross-Sectional Survey | |
| Meenakshi Gautham,Rosalind Miller,Sonia Rego,Catherine Goodman |
| Antibiotics.2022;11(4)523 |
| [DOI] |
|
| 2 | Fixed-dose combinations banned in India: is it the right decision? An eye-opening review | |
| Marlon Ramcy Henry Miranda,Akhilesh Dubey,Ravi G.S,R Narayana Charyulu |
| Expert Opinion on Drug Safety.2019;18(10)977 |
| [DOI] |
|
| 3 | Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries | |
| Brian Godman,Holly McCabe,Trudy D Leong,Debjani Mueller,Antony P. Martin,Iris Hoxha,Julius C. Mwita,Godfrey Mutashambara Rwegerera,Amos Massele,Juliana de Oliveira Costa,Renata Cristina Rezende Macedo do Nascimento,Livia Lovato Pires de Lemos,Konstantin Tachkov,Petya Milushewa,Okwen Patrick,Loveline Lum Niba,Ott Laius,Israel Sefah,Suhaj Abdulsalim,Fatemeh Soleymani,Anastasia N Guantai,Loice Achieng,Margaret Oluka,Arianit Jakupi,Konstantins Logviss,Mohamed Azmi Hassali,Dan Kibuule,Francis Kalemeera,Mwangana Mubita,Joseph Fadare,Olayinka O. Ogunleye,Zikria Saleem,Shazhad Hussain,Tomasz Bochenek,Ileana Mardare,Alian A. Alrasheedy,Jurij Furst,Dominik Tomek,Vanda Markovic-Pekovic,Enos M. Rampamba,Abubakr Alfadl,Adefolarin A Amu,Zinhle Matsebula,Thuy Nguyen Thi Phuong,Binh Nguyen Thanh,Aubrey Chichonyi Kalungia,Trust Zaranyika,Nyasha Masuka,Ioana D. Olaru,Janney Wale,Ruaraidh Hill,Amanj Kurdi,Angela Timoney,Stephen Campbell,Johanna C. Meyer |
| Expert Review of Pharmacoeconomics & Outcomes Research.2020;20(1)1 |
| [DOI] |
|
| 4 | Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries | |
| Subish Palaian |
| Expert Review of Pharmacoeconomics & Outcomes Research.2018;20(1)145 |
| [DOI] |
|
| 5 | Fixed-dose combinations: An essential for rational preparation | |
| Pugazhenthan Thangaraju,ShobanBabu Varthya,Sajitha Venkatesan |
| Indian Journal of Pharmacology.2021;53(2)170 |
| [DOI] |
|
| 6 | Fixed-dose combinations: An essential for rational preparation | |
| Abialbon Paul |
| Indian Journal of Pharmacology.2019;53(2)307 |
| [DOI] |
|
| 7 | Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain | |
| Ion G. Motofei,David L. Rowland,Mirela Manea,Simona R. Georgescu,Ioana Paunica,Ioanel Sinescu |
| Clinical Drug Investigation.2017;37(6)511 |
| [DOI] |
|
| 8 | From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets | |
| Muzna Sadia,Abdullah Isreb,Ibrahim Abbadi,Mohammad Isreb,David Aziz,Amjad Selo,Peter Timmins,Mohamed A. Alhnan |
| European Journal of Pharmaceutical Sciences.2018;123(6)484 |
| [DOI] |
|
| 9 | Identification of At-risk Pregnant Population for Over-the-Counter Drug Usage in Low-Resource Settings | |
| Aashima Arora,M. Praveen Kumar,Aishwarya Anand,Lekha Saha,Pradip Kumar Saha,Ankit Kumar,Haresh Shendge,Amol N. Patil |
| The Journal of Obstetrics and Gynecology of India.2021;71(6)600 |
| [DOI] |
|
| 10 | Improving access to medicines by popularising generics: a study of ‘India’s People’s Medicine’ scheme in two districts of Maharashtra | |
| Sonam Lavtepatil,Soumitra Ghosh |
| BMC Health Services Research.2022;22(1)600 |
| [DOI] |
|
| 11 | Communication with Physicians: a Tool for Improving Appropriate Antibiotic Use in the Absence of Regulatory Mechanisms | |
| Purabi Barman,Tarun Thukral,Shimpi Chopra |
| Current Treatment Options in Infectious Diseases.2021;13(1)1 |
| [DOI] |
|
| 12 | Indian Pharmaceutical Industries Current Status and Togetherness to Overcome Speed Breakers in Term of Quality Issues to make India as a Global Pharma Destination | |
| Vikas Rathee,Kapil Pihwal,Neelam Pawar,Sheikh Aamir,Mohammad S. Alam,Kavita Bahmani |
| Applied Drug Research, Clinical Trials and Regulatory Affairs.2021;8(1)19 |
| [DOI] |
|
| 13 | Ofloxacin-ornidazole fixed-dose combination medication-induced pancreatitis with positive rechallenge | |
| Nikhil Bush,Vishal Sharma,K Chandrahasan,AmolN Patil |
| Journal of Family Medicine and Primary Care.2020;9(6)3157 |
| [DOI] |
|
| 14 | Efficacy and Safety of Pregabalin Prolonged Release–Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized Study | |
| Amit B. Yeole,G. Sree Ranga Lakshmi,C. J. Selvakumar,Vijay G. Goni,C. L. Nawal,Bhanoth J. Valya,Brijesh J. Patel,Rohit D. Patel,Eknath D. Pawar,Ranajit Panigrahi,Ashish Y. Kumar,Shrinivas S. Shintre,Prashant H. Devkare,Shruti K. Dharmadhikari,Sanjay Y. Choudhari,Maulik S. Doshi,Suyog C. Mehta,Sadhna J. Joglekar |
| Pain and Therapy.2022;11(4)1451 |
| [DOI] |
|
| 15 | Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i?+?DPP4i in the Indian Diabetes Setting | |
| Manoj Chadha,Ashok Kumar Das,Prasun Deb,Kalyan Kumar Gangopadhyay,Shashank Joshi,Jothydev Kesavadev,Rajiv Kovil,Surender Kumar,Anoop Misra,Viswanathan Mohan |
| Diabetes Therapy.2022;13(5)1097 |
| [DOI] |
|
| 16 | Fixed Dose Combinations in Indian Medicine Market - A SWOT Analysis | |
| Revikumar KG |
| MOJ Bioequivalence & Bioavailability.2017;4(3)1097 |
| [DOI] |
|
| 17 | Assessment of utilization pattern of fixed dose drug combinations in primary, secondary and tertiary healthcare centers in Nepal: a cross-sectional study | |
| Arjun Poudel,Mohamed Izham Mohamed Ibrahim,Pranaya Mishra,Subish Palaian |
| BMC Pharmacology and Toxicology.2017;18(1)1097 |
| [DOI] |
|
| 18 | Emergence of recalcitrant dermatophytosis in India | |
| Shyam B Verma |
| The Lancet Infectious Diseases.2018;18(7)718 |
| [DOI] |
|
| 19 | Developing a latent class analysis model to identify at-risk populations among people using medicine without prescription | |
| Praveen Kumar-M,Rahul Mahajan,S Kathirvel,Naveen Hegde,Ashish Kumar Kakkar,Amol N. Patil |
| Expert Review of Clinical Pharmacology.2020;13(12)1411 |
| [DOI] |
|
| 20 | Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel | |
| Sanjay Kalra,AK Das,G Priya,S Ghosh,RN Mehrotra,S Das,P Shah,S Bajaj,V Deshmukh,D Sanyal,S Chandrasekaran,D Khandelwal,A Joshi,T Nair,F Eliana,H Permana,MD Fariduddin,PK Shrestha,D Shrestha,S Kahandawa,M Sumanathilaka,A Shaheed,AA Rahim,A Orabi,A Al-ani,W Hussein,D Kumar,K Shaikh |
| Journal of Family Medicine and Primary Care.2020;9(11)5450 |
| [DOI] |
|
| 21 | Importance of patents and data exclusivity in fixed-dose combination medicinal products | |
| Marija Mitkovska,Katerina Anchevska Netkovska,Aleksandra Grozdanova,Ana Poceva Panovska,Ema Kikovska Stojanovska |
| Macedonian Pharmaceutical Bulletin.2019;65(2)33 |
| [DOI] |
|
| 22 | Antibiotic Use and Misuse in Dentistry in India—A Systematic Review | |
| Aarthi Bhuvaraghan,Rebecca King,Harriet Larvin,Vishal R. Aggarwal |
| Antibiotics.2021;10(12)1459 |
| [DOI] |
|
| 23 | Pharmaceutical Market and Drug Price Policy in India | |
| Venkatanarayana Motkuri,Rudra Narayan Mishra |
| Review of Development and Change.2020;25(1)30 |
| [DOI] |
|
| 24 | Fixed dose combinations of anti-tubercular, antimalarial and antiretroviral medicines on the Indian market: critical analysis of ubiquity, sales and regulatory status | |
| Virendra S. Ligade,Tanmay M. Thakar,Swapnil J. Dengale |
| Tropical Medicine & International Health.2019;24(2)238 |
| [DOI] |
|
| 25 | Unorthodox Parenteral ß-Lactam and ß-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care | |
| Snehal Palwe,Balaji Veeraraghavan,Hariharan Periasamy,Kshama Khobragade,Arun S. Kharat |
| Antimicrobial Agents and Chemotherapy.2020;64(5)238 |
| [DOI] |
|
